EcoDrugPlus

Cyclin Dependent Kinase 7

Ensembl ID : ENSSLUG00000022205
Gene Symbol: CDK7
3 Cross references
218 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSSLUG00000020382
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSSLUG00000023513
Gene Symbol: LOC116053605
3 Cross references
247 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSSLUG00000000372
Gene Symbol: CDK2
1 Cross references
202 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSSLUG00000025606
Gene Symbol: CYSLTR1
1 Cross references
176 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSSLUG00000016657
Gene Symbol: CDA
3 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSSLUG00000021874
Gene Symbol: LOC116067552
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSSLUG00000010953
Gene Symbol: LOC116061623
2 Cross references
535 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSSLUG00000017463
Gene Symbol: LOC116062163
2 Cross references
445 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSSLUG00000005150
Gene Symbol: LOC116043019
3 Cross references
551 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSSLUG00000008812
Gene Symbol: CYP19A1
1 Cross references
244 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSSLUG00000023609
Gene Symbol: LOC116035861
3 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).